![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | |
Founding Date | Founding Date 2006 | Founding Date 2006 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US |
Employees | Employees 743% increase | Employees 91 |
Financial | ||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods £11.1m (FY, 2025) |
Net income | Net income ($227.4m) (FY, 2021) | Net income £7m (FY, 2025) |
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company